It is the result of collaboration between the North East nanotechnology company Orla Protein Technologies and leading telecoms firm Japan Radio (JR). The venture was assisted by RTC North Ltd
Their new OJ-Bio joint venture is centred on producing state-of-the-art equipment that can be used to test, diagnose and monitor patients anywhere from doctors’ surgeries to the remotest corners of the world.
For help developing links for your company internationally contact Ray Jones or Sandra Innes
22/Jan/2010